世界の男性性腺機能低下症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Male Hypogonadism Therapy Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5838
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、122ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、男性性腺機能低下症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（非経口、経皮、経口、その他）、用途別市場規模（病院、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・男性性腺機能低下症治療の市場動向
・企業の競争状況、市場シェア
・男性性腺機能低下症治療の種類別市場規模と予測2016-2027（非経口、経皮、経口、その他）
・男性性腺機能低下症治療の用途別市場規模と予測2016-2027（病院、ドラッグストア、その他）
・男性性腺機能低下症治療の北米市場規模2016-2027（アメリカ、カナダ）
・男性性腺機能低下症治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・男性性腺機能低下症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・男性性腺機能低下症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・男性性腺機能低下症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Eli Lilly、Pfizer、AbbVie、Novo Nordisk、Merck KGaA、Mylan、Bayer、Teva、Novartis、Abbott、Roche、Endo International、Ipsen、ANI Pharmaceuticals、TherapeuticsMD）
・結論

Male hypogonadism, also known as testosterone deficiency, is a failure of the testes to produce the male sex hormone testosterone, sperm, or both. It can be due to a testicular disorder or the result of a disease process involving the hypothalamus and pituitary gland.

Market Analysis and Insights: Global Male Hypogonadism Therapy Market
The global Male Hypogonadism Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Male Hypogonadism Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Male Hypogonadism Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Male Hypogonadism Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Male Hypogonadism Therapy market.

Global Male Hypogonadism Therapy Scope and Market Size
Male Hypogonadism Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Male Hypogonadism Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Parenteral
Transdermal
Oral
Others

Segment by Application
Hospitals
Drugstores
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Eli Lilly
Pfizer
AbbVie
Novo Nordisk
Merck KGaA
Mylan
Bayer
Teva
Novartis
Abbott
Roche
Endo International
Ipsen
ANI Pharmaceuticals
TherapeuticsMD

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Male Hypogonadism Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Parenteral
1.2.3 Transdermal
1.2.4 Oral
1.2.5 Others
1.3 Market by Application
1.3.1 Global Male Hypogonadism Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Male Hypogonadism Therapy Market Perspective (2016-2027)
2.2 Male Hypogonadism Therapy Growth Trends by Regions
2.2.1 Male Hypogonadism Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Male Hypogonadism Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Male Hypogonadism Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Male Hypogonadism Therapy Industry Dynamic
2.3.1 Male Hypogonadism Therapy Market Trends
2.3.2 Male Hypogonadism Therapy Market Drivers
2.3.3 Male Hypogonadism Therapy Market Challenges
2.3.4 Male Hypogonadism Therapy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Male Hypogonadism Therapy Players by Revenue
3.1.1 Global Top Male Hypogonadism Therapy Players by Revenue (2016-2021)
3.1.2 Global Male Hypogonadism Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Male Hypogonadism Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Male Hypogonadism Therapy Revenue
3.4 Global Male Hypogonadism Therapy Market Concentration Ratio
3.4.1 Global Male Hypogonadism Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Male Hypogonadism Therapy Revenue in 2020
3.5 Male Hypogonadism Therapy Key Players Head office and Area Served
3.6 Key Players Male Hypogonadism Therapy Product Solution and Service
3.7 Date of Enter into Male Hypogonadism Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Male Hypogonadism Therapy Breakdown Data by Type
4.1 Global Male Hypogonadism Therapy Historic Market Size by Type (2016-2021)
4.2 Global Male Hypogonadism Therapy Forecasted Market Size by Type (2022-2027)

5 Male Hypogonadism Therapy Breakdown Data by Application
5.1 Global Male Hypogonadism Therapy Historic Market Size by Application (2016-2021)
5.2 Global Male Hypogonadism Therapy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Male Hypogonadism Therapy Market Size (2016-2027)
6.2 North America Male Hypogonadism Therapy Market Size by Type
6.2.1 North America Male Hypogonadism Therapy Market Size by Type (2016-2021)
6.2.2 North America Male Hypogonadism Therapy Market Size by Type (2022-2027)
6.2.3 North America Male Hypogonadism Therapy Market Size by Type (2016-2027)
6.3 North America Male Hypogonadism Therapy Market Size by Application
6.3.1 North America Male Hypogonadism Therapy Market Size by Application (2016-2021)
6.3.2 North America Male Hypogonadism Therapy Market Size by Application (2022-2027)
6.3.3 North America Male Hypogonadism Therapy Market Size by Application (2016-2027)
6.4 North America Male Hypogonadism Therapy Market Size by Country
6.4.1 North America Male Hypogonadism Therapy Market Size by Country (2016-2021)
6.4.2 North America Male Hypogonadism Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Male Hypogonadism Therapy Market Size (2016-2027)
7.2 Europe Male Hypogonadism Therapy Market Size by Type
7.2.1 Europe Male Hypogonadism Therapy Market Size by Type (2016-2021)
7.2.2 Europe Male Hypogonadism Therapy Market Size by Type (2022-2027)
7.2.3 Europe Male Hypogonadism Therapy Market Size by Type (2016-2027)
7.3 Europe Male Hypogonadism Therapy Market Size by Application
7.3.1 Europe Male Hypogonadism Therapy Market Size by Application (2016-2021)
7.3.2 Europe Male Hypogonadism Therapy Market Size by Application (2022-2027)
7.3.3 Europe Male Hypogonadism Therapy Market Size by Application (2016-2027)
7.4 Europe Male Hypogonadism Therapy Market Size by Country
7.4.1 Europe Male Hypogonadism Therapy Market Size by Country (2016-2021)
7.4.2 Europe Male Hypogonadism Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Male Hypogonadism Therapy Market Size (2016-2027)
8.2 Asia-Pacific Male Hypogonadism Therapy Market Size by Type
8.2.1 Asia-Pacific Male Hypogonadism Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Male Hypogonadism Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Male Hypogonadism Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Male Hypogonadism Therapy Market Size by Application
8.3.1 Asia-Pacific Male Hypogonadism Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Male Hypogonadism Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Male Hypogonadism Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Male Hypogonadism Therapy Market Size by Region
8.4.1 Asia-Pacific Male Hypogonadism Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Male Hypogonadism Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Male Hypogonadism Therapy Market Size (2016-2027)
9.2 Latin America Male Hypogonadism Therapy Market Size by Type
9.2.1 Latin America Male Hypogonadism Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Male Hypogonadism Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Male Hypogonadism Therapy Market Size by Type (2016-2027)
9.3 Latin America Male Hypogonadism Therapy Market Size by Application
9.3.1 Latin America Male Hypogonadism Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Male Hypogonadism Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Male Hypogonadism Therapy Market Size by Application (2016-2027)
9.4 Latin America Male Hypogonadism Therapy Market Size by Country
9.4.1 Latin America Male Hypogonadism Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Male Hypogonadism Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Male Hypogonadism Therapy Market Size (2016-2027)
10.2 Middle East & Africa Male Hypogonadism Therapy Market Size by Type
10.2.1 Middle East & Africa Male Hypogonadism Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Male Hypogonadism Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Male Hypogonadism Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Male Hypogonadism Therapy Market Size by Application
10.3.1 Middle East & Africa Male Hypogonadism Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Male Hypogonadism Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Male Hypogonadism Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Male Hypogonadism Therapy Market Size by Country
10.4.1 Middle East & Africa Male Hypogonadism Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Male Hypogonadism Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Male Hypogonadism Therapy Introduction
11.1.4 Eli Lilly Revenue in Male Hypogonadism Therapy Business (2016-2021)
11.1.5 Eli Lilly Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Male Hypogonadism Therapy Introduction
11.2.4 Pfizer Revenue in Male Hypogonadism Therapy Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Details
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Male Hypogonadism Therapy Introduction
11.3.4 AbbVie Revenue in Male Hypogonadism Therapy Business (2016-2021)
11.3.5 AbbVie Recent Development
11.4 Novo Nordisk
11.4.1 Novo Nordisk Company Details
11.4.2 Novo Nordisk Business Overview
11.4.3 Novo Nordisk Male Hypogonadism Therapy Introduction
11.4.4 Novo Nordisk Revenue in Male Hypogonadism Therapy Business (2016-2021)
11.4.5 Novo Nordisk Recent Development
11.5 Merck KGaA
11.5.1 Merck KGaA Company Details
11.5.2 Merck KGaA Business Overview
11.5.3 Merck KGaA Male Hypogonadism Therapy Introduction
11.5.4 Merck KGaA Revenue in Male Hypogonadism Therapy Business (2016-2021)
11.5.5 Merck KGaA Recent Development
11.6 Mylan
11.6.1 Mylan Company Details
11.6.2 Mylan Business Overview
11.6.3 Mylan Male Hypogonadism Therapy Introduction
11.6.4 Mylan Revenue in Male Hypogonadism Therapy Business (2016-2021)
11.6.5 Mylan Recent Development
11.7 Bayer
11.7.1 Bayer Company Details
11.7.2 Bayer Business Overview
11.7.3 Bayer Male Hypogonadism Therapy Introduction
11.7.4 Bayer Revenue in Male Hypogonadism Therapy Business (2016-2021)
11.7.5 Bayer Recent Development
11.8 Teva
11.8.1 Teva Company Details
11.8.2 Teva Business Overview
11.8.3 Teva Male Hypogonadism Therapy Introduction
11.8.4 Teva Revenue in Male Hypogonadism Therapy Business (2016-2021)
11.8.5 Teva Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Male Hypogonadism Therapy Introduction
11.9.4 Novartis Revenue in Male Hypogonadism Therapy Business (2016-2021)
11.9.5 Novartis Recent Development
11.10 Abbott
11.10.1 Abbott Company Details
11.10.2 Abbott Business Overview
11.10.3 Abbott Male Hypogonadism Therapy Introduction
11.10.4 Abbott Revenue in Male Hypogonadism Therapy Business (2016-2021)
11.10.5 Abbott Recent Development
11.11 Roche
11.11.1 Roche Company Details
11.11.2 Roche Business Overview
11.11.3 Roche Male Hypogonadism Therapy Introduction
11.11.4 Roche Revenue in Male Hypogonadism Therapy Business (2016-2021)
11.11.5 Roche Recent Development
11.12 Endo International
11.12.1 Endo International Company Details
11.12.2 Endo International Business Overview
11.12.3 Endo International Male Hypogonadism Therapy Introduction
11.12.4 Endo International Revenue in Male Hypogonadism Therapy Business (2016-2021)
11.12.5 Endo International Recent Development
11.13 Ipsen
11.13.1 Ipsen Company Details
11.13.2 Ipsen Business Overview
11.13.3 Ipsen Male Hypogonadism Therapy Introduction
11.13.4 Ipsen Revenue in Male Hypogonadism Therapy Business (2016-2021)
11.13.5 Ipsen Recent Development
11.14 ANI Pharmaceuticals
11.14.1 ANI Pharmaceuticals Company Details
11.14.2 ANI Pharmaceuticals Business Overview
11.14.3 ANI Pharmaceuticals Male Hypogonadism Therapy Introduction
11.14.4 ANI Pharmaceuticals Revenue in Male Hypogonadism Therapy Business (2016-2021)
11.14.5 ANI Pharmaceuticals Recent Development
11.15 TherapeuticsMD
11.15.1 TherapeuticsMD Company Details
11.15.2 TherapeuticsMD Business Overview
11.15.3 TherapeuticsMD Male Hypogonadism Therapy Introduction
11.15.4 TherapeuticsMD Revenue in Male Hypogonadism Therapy Business (2016-2021)
11.15.5 TherapeuticsMD Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Male Hypogonadism Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Parenteral
Table 3. Key Players of Transdermal
Table 4. Key Players of Oral
Table 5. Key Players of Others
Table 6. Global Male Hypogonadism Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Male Hypogonadism Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Male Hypogonadism Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Male Hypogonadism Therapy Market Share by Regions (2016-2021)
Table 10. Global Male Hypogonadism Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Male Hypogonadism Therapy Market Share by Regions (2022-2027)
Table 12. Male Hypogonadism Therapy Market Trends
Table 13. Male Hypogonadism Therapy Market Drivers
Table 14. Male Hypogonadism Therapy Market Challenges
Table 15. Male Hypogonadism Therapy Market Restraints
Table 16. Global Male Hypogonadism Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Male Hypogonadism Therapy Market Share by Players (2016-2021)
Table 18. Global Top Male Hypogonadism Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Male Hypogonadism Therapy as of 2020)
Table 19. Ranking of Global Top Male Hypogonadism Therapy Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Male Hypogonadism Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Male Hypogonadism Therapy Product Solution and Service
Table 23. Date of Enter into Male Hypogonadism Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Male Hypogonadism Therapy Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Male Hypogonadism Therapy Revenue Market Share by Type (2016-2021)
Table 27. Global Male Hypogonadism Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Male Hypogonadism Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Male Hypogonadism Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Male Hypogonadism Therapy Revenue Market Share by Application (2016-2021)
Table 31. Global Male Hypogonadism Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Male Hypogonadism Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Male Hypogonadism Therapy Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Male Hypogonadism Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Male Hypogonadism Therapy Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Male Hypogonadism Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Male Hypogonadism Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Male Hypogonadism Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Male Hypogonadism Therapy Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Male Hypogonadism Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Male Hypogonadism Therapy Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Male Hypogonadism Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Male Hypogonadism Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Male Hypogonadism Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Male Hypogonadism Therapy Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Male Hypogonadism Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Male Hypogonadism Therapy Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Male Hypogonadism Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Male Hypogonadism Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Male Hypogonadism Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Male Hypogonadism Therapy Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Male Hypogonadism Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Male Hypogonadism Therapy Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Male Hypogonadism Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Male Hypogonadism Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Male Hypogonadism Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Male Hypogonadism Therapy Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Male Hypogonadism Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Male Hypogonadism Therapy Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Male Hypogonadism Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Male Hypogonadism Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Male Hypogonadism Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 63. Eli Lilly Company Details
Table 64. Eli Lilly Business Overview
Table 65. Eli Lilly Male Hypogonadism Therapy Product
Table 66. Eli Lilly Revenue in Male Hypogonadism Therapy Business (2016-2021) & (US$ Million)
Table 67. Eli Lilly Recent Development
Table 68. Pfizer Company Details
Table 69. Pfizer Business Overview
Table 70. Pfizer Male Hypogonadism Therapy Product
Table 71. Pfizer Revenue in Male Hypogonadism Therapy Business (2016-2021) & (US$ Million)
Table 72. Pfizer Recent Development
Table 73. AbbVie Company Details
Table 74. AbbVie Business Overview
Table 75. AbbVie Male Hypogonadism Therapy Product
Table 76. AbbVie Revenue in Male Hypogonadism Therapy Business (2016-2021) & (US$ Million)
Table 77. AbbVie Recent Development
Table 78. Novo Nordisk Company Details
Table 79. Novo Nordisk Business Overview
Table 80. Novo Nordisk Male Hypogonadism Therapy Product
Table 81. Novo Nordisk Revenue in Male Hypogonadism Therapy Business (2016-2021) & (US$ Million)
Table 82. Novo Nordisk Recent Development
Table 83. Merck KGaA Company Details
Table 84. Merck KGaA Business Overview
Table 85. Merck KGaA Male Hypogonadism Therapy Product
Table 86. Merck KGaA Revenue in Male Hypogonadism Therapy Business (2016-2021) & (US$ Million)
Table 87. Merck KGaA Recent Development
Table 88. Mylan Company Details
Table 89. Mylan Business Overview
Table 90. Mylan Male Hypogonadism Therapy Product
Table 91. Mylan Revenue in Male Hypogonadism Therapy Business (2016-2021) & (US$ Million)
Table 92. Mylan Recent Development
Table 93. Bayer Company Details
Table 94. Bayer Business Overview
Table 95. Bayer Male Hypogonadism Therapy Product
Table 96. Bayer Revenue in Male Hypogonadism Therapy Business (2016-2021) & (US$ Million)
Table 97. Bayer Recent Development
Table 98. Teva Company Details
Table 99. Teva Business Overview
Table 100. Teva Revenue in Male Hypogonadism Therapy Business (2016-2021) & (US$ Million)
Table 101. Teva Recent Development
Table 102. Novartis Company Details
Table 103. Novartis Business Overview
Table 104. Novartis Male Hypogonadism Therapy Product
Table 105. Novartis Revenue in Male Hypogonadism Therapy Business (2016-2021) & (US$ Million)
Table 106. Novartis Recent Development
Table 107. Abbott Company Details
Table 108. Abbott Business Overview
Table 109. Abbott Male Hypogonadism Therapy Product
Table 110. Abbott Revenue in Male Hypogonadism Therapy Business (2016-2021) & (US$ Million)
Table 111. Abbott Recent Development
Table 112. Roche Company Details
Table 113. Roche Business Overview
Table 114. Roche Male Hypogonadism Therapy Product
Table 115. Roche Revenue in Male Hypogonadism Therapy Business (2016-2021) & (US$ Million)
Table 116. Roche Recent Development
Table 117. Endo International Company Details
Table 118. Endo International Business Overview
Table 119. Endo International Male Hypogonadism Therapy Product
Table 120. Endo International Revenue in Male Hypogonadism Therapy Business (2016-2021) & (US$ Million)
Table 121. Endo International Recent Development
Table 122. Ipsen Company Details
Table 123. Ipsen Business Overview
Table 124. Ipsen Male Hypogonadism Therapy Product
Table 125. Ipsen Revenue in Male Hypogonadism Therapy Business (2016-2021) & (US$ Million)
Table 126. Ipsen Recent Development
Table 127. ANI Pharmaceuticals Company Details
Table 128. ANI Pharmaceuticals Business Overview
Table 129. ANI Pharmaceuticals Male Hypogonadism Therapy Product
Table 130. ANI Pharmaceuticals Revenue in Male Hypogonadism Therapy Business (2016-2021) & (US$ Million)
Table 131. ANI Pharmaceuticals Recent Development
Table 132. TherapeuticsMD Company Details
Table 133. TherapeuticsMD Business Overview
Table 134. TherapeuticsMD Male Hypogonadism Therapy Product
Table 135. TherapeuticsMD Revenue in Male Hypogonadism Therapy Business (2016-2021) & (US$ Million)
Table 136. TherapeuticsMD Recent Development
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Male Hypogonadism Therapy Market Share by Type: 2020 VS 2027
Figure 2. Parenteral Features
Figure 3. Transdermal Features
Figure 4. Oral Features
Figure 5. Others Features
Figure 6. Global Male Hypogonadism Therapy Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Drugstores Case Studies
Figure 9. Others Case Studies
Figure 10. Male Hypogonadism Therapy Report Years Considered
Figure 11. Global Male Hypogonadism Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Male Hypogonadism Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Male Hypogonadism Therapy Market Share by Regions: 2020 VS 2027
Figure 14. Global Male Hypogonadism Therapy Market Share by Regions (2022-2027)
Figure 15. Global Male Hypogonadism Therapy Market Share by Players in 2020
Figure 16. Global Top Male Hypogonadism Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Male Hypogonadism Therapy as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Male Hypogonadism Therapy Revenue in 2020
Figure 18. Global Male Hypogonadism Therapy Revenue Market Share by Type (2016-2021)
Figure 19. Global Male Hypogonadism Therapy Revenue Market Share by Type (2022-2027)
Figure 20. North America Male Hypogonadism Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Male Hypogonadism Therapy Market Share by Type (2016-2027)
Figure 22. North America Male Hypogonadism Therapy Market Share by Application (2016-2027)
Figure 23. North America Male Hypogonadism Therapy Market Share by Country (2016-2027)
Figure 24. United States Male Hypogonadism Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Male Hypogonadism Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Male Hypogonadism Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Male Hypogonadism Therapy Market Share by Type (2016-2027)
Figure 28. Europe Male Hypogonadism Therapy Market Share by Application (2016-2027)
Figure 29. Europe Male Hypogonadism Therapy Market Share by Country (2016-2027)
Figure 30. Germany Male Hypogonadism Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Male Hypogonadism Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Male Hypogonadism Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Male Hypogonadism Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Male Hypogonadism Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Male Hypogonadism Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Male Hypogonadism Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Male Hypogonadism Therapy Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Male Hypogonadism Therapy Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Male Hypogonadism Therapy Market Share by Region (2016-2027)
Figure 40. China Male Hypogonadism Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Male Hypogonadism Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Male Hypogonadism Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Male Hypogonadism Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Male Hypogonadism Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Male Hypogonadism Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Male Hypogonadism Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Male Hypogonadism Therapy Market Share by Type (2016-2027)
Figure 48. Latin America Male Hypogonadism Therapy Market Share by Application (2016-2027)
Figure 49. Latin America Male Hypogonadism Therapy Market Share by Country (2016-2027)
Figure 50. Mexico Male Hypogonadism Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Male Hypogonadism Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Male Hypogonadism Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Male Hypogonadism Therapy Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Male Hypogonadism Therapy Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Male Hypogonadism Therapy Market Share by Country (2016-2027)
Figure 56. Turkey Male Hypogonadism Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Male Hypogonadism Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Male Hypogonadism Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Eli Lilly Revenue Growth Rate in Male Hypogonadism Therapy Business (2016-2021)
Figure 60. Pfizer Revenue Growth Rate in Male Hypogonadism Therapy Business (2016-2021)
Figure 61. AbbVie Revenue Growth Rate in Male Hypogonadism Therapy Business (2016-2021)
Figure 62. Novo Nordisk Revenue Growth Rate in Male Hypogonadism Therapy Business (2016-2021)
Figure 63. Merck KGaA Revenue Growth Rate in Male Hypogonadism Therapy Business (2016-2021)
Figure 64. Mylan Revenue Growth Rate in Male Hypogonadism Therapy Business (2016-2021)
Figure 65. Bayer Revenue Growth Rate in Male Hypogonadism Therapy Business (2016-2021)
Figure 66. Teva Revenue Growth Rate in Male Hypogonadism Therapy Business (2016-2021)
Figure 67. Novartis Revenue Growth Rate in Male Hypogonadism Therapy Business (2016-2021)
Figure 68. Abbott Revenue Growth Rate in Male Hypogonadism Therapy Business (2016-2021)
Figure 69. Roche Revenue Growth Rate in Male Hypogonadism Therapy Business (2016-2021)
Figure 70. Endo International Revenue Growth Rate in Male Hypogonadism Therapy Business (2016-2021)
Figure 71. Ipsen Revenue Growth Rate in Male Hypogonadism Therapy Business (2016-2021)
Figure 72. ANI Pharmaceuticals Revenue Growth Rate in Male Hypogonadism Therapy Business (2016-2021)
Figure 73. TherapeuticsMD Revenue Growth Rate in Male Hypogonadism Therapy Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

以下、関連資料のご紹介

世界の男性乳がん治療市場規模・現状・予測（2021年-2027年）

Global Male Breast Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4456 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、男性乳がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（投薬、化学療法、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、...

世界の重粒子線治療市場規模・現状・予測（2021年-2027年）

Global Heavy Ion Therapy Market Size, Status and Forecast 2021-2027
QFJ1-5188 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、重粒子線治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（機器、サービス）、用途別市場規模（科学研究所、医療、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界の補助療法市場規模・現状・予測（2021年-2027年）

Global Adjuvant Therapy Market Size, Status and Forecast 2021-2027
QFJ1-3765 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、補助療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、ホルモン療法、その他）、用途別市場規模（病院、医療機関、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界のTCR-T療法試薬市場規模・現状・予測（2021年-2027年）

Global TCR-T Therapy Reagent Market Size, Status and Forecast 2021-2027
QFJ1-4940 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、TCR-T療法試薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（血清試薬、抗体試薬、タンパク質試薬、その他）、用途別市場規模（病院、バイオラボ、その他）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の時差ボケ治療薬市場規模・現状・予測（2021年-2027年）

Global Jet Lag Therapy Pharmaceuticals Market Size, Status and Forecast 2021-2027
QFJ1-5816 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、時差ボケ治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（Rx、OTC）、用途別市場規模（ビジネス旅行者、キャビンクルー、アスリート、季節旅行者、その他）、主要地域別市場規模（北米、アメリカ、欧州...

世界のパラフィン理学療法市場規模・現状・予測（2021年-2027年）

Global Paraffin Physical Therapy Market Size, Status and Forecast 2021-2027
QFJ1-4653 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、パラフィン理学療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（即時使用可能パラフィン理学療法、即時加熱可能パラフィン理学療法）、用途別市場規模（病院、クリニック、若返りセンター）、主要地域別市場規...

世界の神経再生治療市場規模・現状・予測（2021年-2027年）

Global Neuroregeneration Therapy Market Size, Status and Forecast 2021-2027
QFJ1-4573 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、神経再生治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（末梢神経系の再生、中枢神経系の再生、軸索の再生の阻害）、用途別市場規模（病院、クリニック、研究機関）、主要地域別市場規模（北米、アメリカ、欧...

世界のTIL療法市場規模・現状・予測（2021年-2027年）

Global TIL Therapy Market Size, Status and Forecast 2021-2027
QFJ1-4957 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、TIL療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（単回注入、複数回注入）、用途別市場規模（胃がん、膵臓がん、肝細胞がん、子宮/子宮内膜がん、子宮頸がん、尿道がん、腎細胞がん、その他）、主要地域...

世界の自己細胞療法市場規模・現状・予測（2021年-2027年）

Global Autologous Cell Therapy Market Size, Status and Forecast 2021-2027
QFJ1-3873 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、自己細胞療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（骨髄、表皮）、用途別市場規模（神経内科、整形外科、がん、創傷治癒、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界のα1アンチトリプシン欠乏症増強療法市場規模・現状・予測（2021年-2027年）

Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, Status and Forecast 2021-2027
QFJ1-3783 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、α1アンチトリプシン欠乏症増強療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（グラシア、アララストNP、プロラスチンC、その他）、用途別市場規模（病院、専門診療所）、主要地域別市場規模（北米、アメ...

世界の成長ホルモン欠乏療法市場規模・現状・予測（2021年-2027年） Growth hormone deficiency (GHD) is a medical condition due to not enough growth hormone (GH). ... Some cases are associated with a lack of other pituitary hormones, in which case it is known as combined pituitary hormone deficiency. Diagnosis involves blood tests to measure growth hormone levels. Ma…
世界の男性乳がん治療市場規模・現状・予測（2021年-2027年） Male breast cancer (male breast neoplasm) is a rare cancer in males that originates from the breast. Many males with breast cancer have inherited a BRCA mutation, but there are other causes, including alcohol abuse and exposure to certain hormones and ionizing radiation. Market Analysis and Insights…
世界のエストロゲン補充療法市場規模・現状・予測（2021年-2027年） Estrogen replacement therapy (ERT) is a type of hormone replacement therapy which is used for the treatment or reduction of various symptoms caused as a result of menopause. Market Analysis and Insights: Global Estrogen Replacement Therapy Market The global Estrogen Replacement Therapy market size …
ホルモン補充療法のグローバル市場2021 Hormone replacement therapy refers to the treatment of the patients with hormone deficiency due to conditions such as dwarfism or women nearing menopause, which requires replacement of hormones in the body whose levels have become low. Market competition is intense. Eli Lilly, Pfizer, AbbVie, Novo N…
世界の重粒子線治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Heavy Ion Therapy Market The global Heavy Ion Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a…